PRJEB1986: zebrafish developmental stages transcriptome
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
arid6 | dr11_v1_chr21_+_11244068_11244068 | 0.12 | 6.2e-01 | Click! |
arid5a | dr11_v1_chr8_+_52377516_52377516 | 0.07 | 7.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_53344726 Show fit | 0.89 |
ENSDART00000184395
ENSDART00000170212 |
|
|
chr4_+_15944245 Show fit | 0.77 |
ENSDART00000134594
|
si:dkey-117n7.3 |
|
chr23_+_5631381 Show fit | 0.77 |
ENSDART00000149143
|
plakophilin 1a |
|
chr2_-_44280061 Show fit | 0.73 |
ENSDART00000136818
|
myelin protein zero |
|
chr4_-_8043839 Show fit | 0.72 |
ENSDART00000190047
ENSDART00000057567 |
si:ch211-240l19.5 |
|
chr10_+_15967341 Show fit | 0.67 |
ENSDART00000115130
ENSDART00000189687 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
chr19_-_1948236 Show fit | 0.67 |
ENSDART00000163344
|
zinc and ring finger 2a |
|
chr3_-_38915998 Show fit | 0.65 |
ENSDART00000141886
|
si:dkey-106c17.2 |
|
chr20_-_9755546 Show fit | 0.61 |
ENSDART00000152498
ENSDART00000152239 |
si:dkey-63j12.4 |
|
chr23_+_383782 Show fit | 0.60 |
ENSDART00000055148
|
zgc:101663 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.6 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.1 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.5 | GO:1904088 | regulation of convergent extension involved in axis elongation(GO:1901232) positive regulation of epiboly involved in gastrulation with mouth forming second(GO:1904088) |
0.1 | 0.5 | GO:0060004 | reflex(GO:0060004) vestibular reflex(GO:0060005) |
0.0 | 0.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.5 | GO:0019835 | cytolysis(GO:0019835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |